News & Updates
Filter by Specialty:
Romosozumab prevents new vertebral fractures in postmenopausal women with osteoporosis
Twelve months of treatment with romosozumab produce marked reductions in new vertebral fractures, especially moderate-to-severe fractures, among postmenopausal women with osteoporosis, according to a study.
Romosozumab prevents new vertebral fractures in postmenopausal women with osteoporosis
29 Sep 2021
Low-carb diets may improve renal, CV risk factors in T2D patients
In individuals with type 2 diabetes (T2D), low-carbohydrate diets (LCDs) may improve renal and cardiovascular (CV) risk factors, suggests a review from the UK.
Low-carb diets may improve renal, CV risk factors in T2D patients
29 Sep 2021
Low-intensity shockwave with PDE-5i safe, effective for erectile dysfunction
The combination of low-intensity shockwave therapy (Li-ESWT) with phosphodiesterase 5 inhibitor (PDE-5i) medication safely improves erectile function in vasculogenic erectile dysfunction (ED) patients who had failed first-line oral therapy, a recent study has found.
Low-intensity shockwave with PDE-5i safe, effective for erectile dysfunction
29 Sep 2021
Add-on metoprolol of no benefit to high-risk prostate cancer patients
Use of metoprolol among high-risk prostate cancer patients receiving androgen deprivation therapy does not appear to improve oncological outcomes, as shown in a study.
